skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: European Journal Of Haematology remover assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Validation of the Alternative International Prognostic Score‐E (AIPS‐E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O‐CLL1‐GISL protocol
Validation of the Alternative International Prognostic Score‐E (AIPS‐E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O‐CLL1‐GISL protocol
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validation of the Alternative International Prognostic Score‐E (AIPS‐E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O‐CLL1‐GISL protocol

Morabito, Fortunato ; Tripepi, Giovanni ; Vigna, Ernesto ; Bossio, Sabrina ; D’Arrigo, Graziella ; Martino, Enrica Antonia ; Storino, Francesca ; Recchia, Anna Grazia ; Fronza, Gilberto ; Di Raimondo, Francesco ; Colombo, Monica ; Fais, Franco ; Neri, Antonino ; Cutrona, Giovanna ; Ferrarini, Manlio ; Gentile, Massimo

European journal of haematology, 2021-06, Vol.106 (6), p.831-835 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression

Matthews, Christine ; Catherwood, Mark A. ; Morris, T. C. M. ; Kettle, Paul J. ; Drake, Mary B. ; Gilmore, William S. ; Alexander, H. Denis

European journal of haematology, 2006-10, Vol.77 (4), p.309-317 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model

Molica, Stefano ; Giannarelli, Diana ; Mirabelli, Rosanna ; Levato, Luciano ; Russo, Antonio ; Linardi, Maria ; Gentile, Massimo ; Morabito, Fortunato

European journal of haematology, 2016-01, Vol.96 (1), p.72-77 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

Brieghel, Christian ; Galle, Veerle ; Agius, Rudi ; da Cunha‐Bang, Caspar ; Andersen, Michael A. ; Vlummens, Philip ; Mattsson, Mattias ; Rosenquist, Richard ; Smedby, Karin E. ; Herling, Carmen D. ; Bahlo, Jasmin ; Hallek, Michael ; Lundgren, Jens D. ; Offner, Fritz ; Niemann, Carsten U.

European journal of haematology, 2022-05, Vol.108 (5), p.369-378 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals

Elizabeth, Smyth ; Aidan, Kelly ; David, O' Brien ; Deirdre, Waldron ; Sarah, Brophy ; Emer, Atkinson ; Kanthi, Perera ; Crotty, Gerard M. ; Aileen, Walsh ; Michelle, Connolly ; Ruth, Clifford ; Hilary, O'Leary ; Ashique, Khan ; Bacon, Christopher L. ; Emily, Smyth ; McElligott, Anthony M. ; Fiona, Quinn ; Elisabeth, Vandenberghe ; Carmel, Waldron

European journal of haematology, 2022-11, Vol.109 (5), p.441-446 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

Chow, Kai Uwe ; Kim, Soo-Zin ; von Neuhoff, Nils ; Schlegelberger, Brigitte ; Stilgenbauer, Stephan ; Wunderle, Lydia ; Cordes, Hans-Joerg ; Bergmann, Lothar

European journal of haematology, 2011-11, Vol.87 (5), p.426-433 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group

Shvidel, Lev ; Tadmor, Tamar ; Braester, Andrei ; Bairey, Osnat ; Rahimi-Levene, Naomi ; Herishanu, Yair ; Klepfish, Abraham ; Ruchlemer, Rosa ; Berrebi, Alain ; Polliack, Aaron

European journal of haematology, 2014-07, Vol.93 (1), p.29-33 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL

González‐Gascón y Marín, Isabel ; Martín, Ana África ; Hernández‐Sanchez, María ; Robledo, Cristina ; Hermosín, María Lourdes ; Heras, Natalia ; Lacalle, Laura ; Galende, Josefina ; Arriba, Felipe ; Rodríguez‐Vicente, Ana Eugenia ; Hernández, José‐Ángel ; Hernández‐Rivas, Jesús María

European journal of haematology, 2017-02, Vol.98 (2), p.142-148 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
Disease burden of chronic lymphocytic leukaemia within the European Union
Disease burden of chronic lymphocytic leukaemia within the European Union
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disease burden of chronic lymphocytic leukaemia within the European Union

Watson, Louise ; Wyld, Peter ; Catovsky, Daniel

European journal of haematology, 2008-10, Vol.81 (4), p.253-258 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia

Willander, Kerstin ; Ungerbäck, Jonas ; Karlsson, Karin ; Fredrikson, Mats ; Söderkvist, Peter ; Linderholm, Mats

European journal of haematology, 2010-09, Vol.85 (3), p.251-256 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.